Neuropsychiatric Safety of GLP-1 Receptor Agonists and Tirzepatide in Adults with Type 2 Diabetes Mellitus or Obesity
Rambam Maimonides medical journal · 2026 Oct 26 · Jani HT, Levine H, Patel A et
MH
By Maren Holt · Senior Reporter, GLP-1
Oct 25 20:00 ETSource: Rambam Maimonides medical journal
From the source
Read at pubmed.ncbi.nlm.nih.govNeuropsychiatric Safety of GLP-1 Receptor Agonists and Tirzepatide in Adults with Type 2 Diabetes Mellitus or Obesity
Rambam Maimonides medical journal · 2026 Oct 26 · Jani HT, Levine H, Patel A et al.
Source URL https://pubmed.ncbi.nlm.nih.gov/42957176/
